Lansoprazolo Almus

Lansoprazole, the active ingredient in Lansoprazolo Almus, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to manage conditions such as gastroesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazolo Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole belongs to the proton pump inhibitor class and acts on gastric acid secretion pathways. It is indicated for the following conditions: - Gastroesophageal reflux disease (GERD): reduces acid exposure and relieves heartburn and regurgitation. - Erosive esophagitis: promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: supports ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication: used in combination therapy to improve bacterial eradication rates.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools may appear. - Nausea: occasional feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Liver injury: jaundice or elevated liver enzymes. - Low magnesium levels: muscle cramps or irregular heartbeat. - Clostridium difficile infection: severe diarrhea. - Interstitial nephritis: kidney inflammation. - Stevens‑Johnson syndrome: serious skin reactions.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: use with caution in liver disease. - Monitor for drug interactions: especially with anticoagulants and antiretrovirals. - Avoid prolonged use without supervision: risk of nutrient malabsorption. - Use the lowest effective dose: to minimize adverse effects. - Store at ambient temperature: keep in the original pack, protect from moisture.

Lansoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atorvastatin: increased statin exposure. - Methotrexate: elevated toxicity risk.

Moderate Interactions (Monitor Closely): - Digoxin: altered absorption. - Phenytoin: decreased plasma levels. - Calcium carbonate: reduced efficacy of acid suppression.